Goldenwell Biotech, Inc.

OTCPK:GWLL Voorraadrapport

Marktkapitalisatie: US$19.8m

Goldenwell Biotech Beheer

Beheer criteriumcontroles 2/4

Goldenwell Biotech's CEO is Shuang Liu, appointed in Aug 2019, has a tenure of 5.08 years. directly owns 41.41% of the company’s shares, worth $8.20M. The average tenure of the management team and the board of directors is 5.1 years and 5.1 years respectively.

Belangrijke informatie

Shuang Liu

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO5.1yrs
Eigendom CEO41.4%
Management gemiddelde ambtstermijn5.1yrs
Gemiddelde ambtstermijn bestuur5.1yrs

Recente managementupdates

Geen updates

Recent updates


CEO

Shuang Liu (60 yo)

5.1yrs

Tenure

Mr. Shuang Liu is President, Chief Executive Officer and Director at Goldenwell Biotech, Inc. since August 20, 2019 and is its Chairman. Since December 2012, Mr. Liu is our principal accounting officer and...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Shuang Liu
Chairman5.1yrsgeen gegevens41.41%
$ 8.2m
Hua Xie
Secretary5.1yrsgeen gegevens5.05%
$ 1.0m
Li Yang
Treasurer & Director5.1yrsgeen gegevens10.1%
$ 2.0m

5.1yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: GWLL's management team is seasoned and experienced (5.1 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Shuang Liu
Chairman5.1yrsgeen gegevens41.41%
$ 8.2m
Hua Xie
Secretary5.1yrsgeen gegevens5.05%
$ 1.0m
Li Yang
Treasurer & Director5.1yrsgeen gegevens10.1%
$ 2.0m

5.1yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: GWLL's board of directors are considered experienced (5.1 years average tenure).